Article Details
Retrieved on: 2023-01-09 16:57:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca has entered an agreement to acquire CinCor in a deal worth up to $1.8bn, in order to expand its pipeline of cardiorenal drugs.
Article found on: www.siliconrepublic.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here